Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Multiple Sclerosis Treatment
100%
COVID-19
100%
Disease-modifying Therapy
80%
Pediatric multiple Sclerosis
60%
Pediatric Neurologist
40%
Multiple Sclerosis
20%
Interferon-α (IFN-α)
20%
Treatment Choice
20%
Practice Patterns
20%
Online Survey
20%
Demographic Data
20%
Highly Effective
20%
Off-label Use
20%
Survey Results
20%
Neurologist
20%
Therapeutic Trial
20%
Early Start
20%
Future Therapeutics
20%
Data Treatment
20%
Fingolimod
20%
Prescribing Patterns
20%
Attitudes toward Treatment
20%
Treatment De-escalation
20%
Prescribing Practices
20%
Nursing and Health Professions
Multiple Sclerosis
100%
COVID-19
100%
Pediatrics
100%
Diseases
80%
Neurologist
60%
Practice Guideline
20%
Interferon
20%
Off-Label Use
20%
Fingolimod
20%
Medicine and Dentistry
Pediatrics
100%
Treatment of Multiple Sclerosis
100%
COVID-19
100%
Multiple Sclerosis
80%
Disease Modifying Therapy
80%
Interferon
20%
Off-Label Use
20%
Fingolimod
20%
Social Sciences
Multiple Sclerosis
100%
COVID 19 Epidemic
100%
Pediatrics
100%
Diseases
80%
COVID-19
40%
Online Survey
20%
Study Group
20%
Legal Procedure
20%